DailyIQ
DailyIQ
Last updated1 minute ago

NBTX·Nanobiotix S.A.

$30.66
-1.59 (-4.95%)
After Hours
High
$32.35
Open
$31.50
Market Cap
1.48B
52W High
$57.14
Low
$30.32
P. Close
$30.66
P/E
-
52W Low
$19.14
Fwd P/E
-182.77
DailyIQ Est.
$58.38
Inst. Own.
11.8%
Short Interest
0.41%
Days to Cover
1.2
Technical Score (1D)
44
BEARISH
News Sentiment
51
MIXED
On Nov 12, 2026, Nanobiotix (NBTX) filed a routine disclosure regarding its voting rights and shares capital structure. The filing reiterated the company’s compliance with French Commercial Code provisions and the French Financial Markets Authority regulations. No changes to share classes, voting power, or capital structure were reported. The announcement contained no new strategic or financial developments. The filing was a standard regulatory update with no material impact.
LOW TARGET
$30 -2.9%
1 analysts
MEAN TARGET
$54 +75.2%
6 analysts
HIGH TARGET
$69 +125.5%
7 analysts
PRICE RANGE
$29.78 - $69.13
SB / B / H / S / SS
5/6/1/1/1
DAILYIQ EST.
$58.38 (+90.4%)
100/ 100
Strong bullish
Overall: Bullish
✓Analyst target above current price

EPS

EstBeatMiss
No data available
QtrEstActual+/−
Q3'26 - - -

Revenue

EstBeatMiss
No data available
QtrEstActual+/−
Q3'26 - - -

Market Data

NBTX Stock Snapshot

NEUTRAL44/100
$30.66+$0.00 (0.0%)
Market cap
1.48B
Day range
$30.32 – $32.34
News sentiment
51/100 · Neutral
Analyst target
$53.72 (+75.2%)
Consensus
Buy · 14 analysts
52-week range+60.2% off low · -46.4% from high
$19.14$57.14
Price $30.66 DailyIQ Est. $58.38

Momentum has flattened on NBTX, leaving the next move dependent on news rather than the chart. Position sizing matters more than usual in a name this size, where volatility is structural.

Behaviour On Record

What NBTX's own history says about today's numbers

Realized volatility (21d)
99.6% 76th pct
Below its peak
-40.3%
vs 200-day average
-5.9%
Up days (1y)
51%

Nanobiotix S.A. is currently running 99.6% annualised volatility over the last 21 sessions. Measured against NBTX's own 4 years of daily returns rather than a market-wide average, that is the 76th percentile — elevated for this stock, against a typical reading of 77.1%.

NBTX is trading -40.3% below its running peak. Across 3 full years on file, its median worst-drawdown-in-a-year was -61.0%, and the deepest was -63.8% in 2021. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.

Price sits -5.9% from its 200-day moving average. Against every other day in its history, that gap ranks at the 49th percentile — close to the gap it normally carries. Over the past year NBTX closed higher on 51% of sessions, and it is currently 1 session into a falling streak.

Overnight risk is measurable too: NBTX has opened more than 2% away from the prior close in 550 of 985 sessions (55.8% of the time), with the largest gaps running +54.1% and -17.3%.

All figures computed from 987 daily closes between 2020-12-14 and 2026-11-12, split-adjusted, recomputed daily. Percentiles are against NBTX's own 6-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of NBTX's sector?

Nanobiotix S.A. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (weakening). Within its narrower Biotechnology industry group, NBTX ranks 9th of 15 tracked industries, weakening.

Sector rank
#2 of 12
Sector state
Weakening
Sector rotation score
82
Industry rank
#9 of 15

Options Market

What is the options market pricing for NBTX?

CallsPuts

For Nanobiotix S.A.'s nearest expiry (2026-11-20, 5 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.00), with at-the-money implied volatility around 142.5%. The options market is pricing roughly a ±16.7% move by that expiry — a range of about $25.54–$35.77.

Put/call ratio (2026-11-20)
0.00
ATM implied volatility
142.5%
Total open interest
11
Expected move by 2026-11-20
±16.7% ($25.54–$35.77)

Analyst Consensus Estimates

What do analysts expect NBTX to earn?

Analysts expect Nanobiotix S.A. to earn -$0.62 per share in the fiscal year ending Dec 2026 and $0.16 in the fiscal year ending Dec 2027, from 2 estimates. These are analyst forecasts, not company guidance, and later years rest on fewer analysts.

Fiscal year endingEPS estimateEPS rangeEPS analystsRevenue estimateRevenue analysts
Dec 2026-$0.62-$0.90 to -$0.332--
Dec 2027$0.16-$0.45 to $0.762--

Analyst Rating Changes

Are analysts turning bullish or bearish on NBTX?

Leerink Partners most recently reiterated its rating on Nanobiotix S.A. to Outperform on Jun 4, 2026 with a price target of $46 (from $37). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Leerink Partners: Outperform
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Jun 4, 2026Leerink PartnersMaintainedOutperform$37 → $46
May 1, 2026UBSMaintainedNeutral$4 → $30
Apr 2, 2026GuggenheimMaintainedBuy$26 → $36
Feb 6, 2026GuggenheimMaintainedBuy$8 → $26
Apr 4, 2025GuggenheimMaintainedBuy$12 → $8
Aug 28, 2024GuggenheimInitiatedBuy$12
Dec 8, 2023Leerink PartnersInitiatedOutperform$11
Jan 6, 2021Evercore ISI GroupInitiatedOutperform-

Corporate Stakes

Which companies own a stake in NBTX?

11.65%held by JNJ

Johnson & Johnson reports a stake in Nanobiotix S.A. on SEC Form 13F: 5.6M shares, about 11.65% of the company, worth $175.2M at the end of Q3 2026. At today's price that stake is worth $172.4M, about 0.02% of JNJ's own market value.

Holder
JNJ
Shares held
5.6M
Stake
11.65%
Value
$175.2M
HolderLast quarterShares% of NBTXValue at filingValue nowChange
Johnson & Johnson JNJUnchanged5.6M11.65%$175.2M$172.4M-1.6%

Form 13F lists US-listed shares held at quarter-end and is filed up to 45 days later. Stakes in private companies are not on it. Value now and Change put those same shares, adjusted for any stock split, at today's price against their reported quarter-end value, so they do not reflect buying or selling since.

News & sentiment

What is the news saying about NBTX?

NBTX rose 42.6% over the month to Nov 13. News tone held between 0 and 100 from Oct 20 to Nov 2, then jumped to 50 on Nov 9.

Daily close and news tone, Oct 13 to Nov 13
$20$30Oct 13Oct 14Oct 15Oct 16Oct 19Oct 20: tone 51Oct 21: tone 100Oct 22Oct 23Oct 26: tone 72Oct 27Oct 28Oct 29Oct 30: tone 32Nov 2: tone 0Nov 3Nov 4Nov 5Nov 6Nov 9: tone 50Nov 10Nov 11Nov 12: tone 51Nov 13Oct 13News toneNov 13123
  1. Oct 20 +14.5%
  2. Oct 22 +13.0%
  3. Oct 27 +14.2%
Latest stories naming Nanobiotix

Technical analysis

How strong is NBTX's momentum right now?

On the daily chart NBTX ranks at the 44th percentile for momentum against 1,062 stocks and ETFs, a neutral reading.

Momentum rank by timeframe0 = weakest, 100 = strongest
See what drives the rankThe inputs behind each timeframe's momentum rank, plus RSI, stochastics, Bollinger Bands and moving averages. Free with an account.

Institutional ownership

Are big funds buying or selling NBTX?

7 of the 10 tracked managers added to NBTX in their latest 13F and 3 trimmed. Together they own 0.1% of the company, worth $1.3M. Jane Street and HRT Financial alone hold 0.1%.

7adding3trimming
Largest holders by stake, latest 13FBar = share of NBTX
  1. $1.0M positionAdded 2.2% last quarter
  2. $826 positionTrimmed 2.9% last quarter
  3. $157.0K positionAdded 95.5% last quarter
  4. $40.5K positionTrimmed 13.5% last quarter
  5. $23.2K positionNew position last quarter
  6. $4.5K positionNew position last quarter
  7. $872 positionNew position last quarter
  8. $343 positionNew position last quarter
  9. $31 positionNew position last quarter
  10. Sold out last quarter

Discover more

How has NBTX done against its peers?

Over the six months to Nov 13, NBTX returned −41.1%. Of the 15 related stocks and ETFs, all did better, led by MRNA at +345.8%.

Change since May 13, through Nov 13
−200%0%+200%+400%+600%May 13JulAugSepOctNov 13MRNA +345.8%NBTX −41.1%